Metastatic recurrence in women diagnosed with non-metastatic breast cancer: a systematic review and meta-analysis
Eileen Morgan(Centre international de recherche sur le cancer), Melina Arnold(Centre international de recherche sur le cancer), Nicoleta Zenovia Antone(Institute of Oncology Prof. Dr. Ion Chiricuta), Julie R. Gralow(American Society of Clinical Oncology), Fátima Cardoso(Université Paris Cité), Sabine Siesling(Netherlands Comprehensive Cancer Organisation), Serban Negoita(National Institutes of Health), Miriam Mutebi(Aga Khan University Nairobi), Paul Walsh, Ryan Woods, Richa Shah(Centre international de recherche sur le cancer), Isabelle Soerjomataram(Centre international de recherche sur le cancer), Karen A. Gelmon(BC Cancer Agency), Esmeralda Ramirez‐Peña(National Institutes of Health), Aude Bardot(Centre international de recherche sur le cancer), Lou Gonsalves(Connecticut Department of Public Health), Oliver Langselius(Centre international de recherche sur le cancer), Clara Frick(German Cancer Research Center), Colette O’Neill(National Cancer Registry), Hanna Fink(Centre international de recherche sur le cancer), Yaqi Su(Centre international de recherche sur le cancer), Jan F. Nygård(Norwegian Institute of Public Health)
Cited by 19
Related Papers
Pembrolizumab for Early Triple-Negative Breast Cancer
|New England Journal of Medicine|2020|3.1k
Palbociclib and Letrozole in Advanced Breast Cancer
|New England Journal of Medicine|2016|2.9k
Breast cancer
|Nature Reviews Disease Primers|2019|2.9k
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2019|2.2k
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k